| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN, USA
2 Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN, USA; Diabetes Research and Training Center, Vanderbilt University, Nashville, TN, USA
3 Diabetes Research and Training Center, Vanderbilt University, Nashville, TN, USA
* To whom correspondence should be addressed. E-mail: stephanie.m.gustavson{at}vanderbilt.edu.
It was previously shown that glucagon and epinephrine have additive effects on both gluconeogenic and glycogenolytic flux. However, the changes in gluconeogenic substrates may have been limiting and thus may have prevented a synergistic effect on gluconeogenesis and a reciprocal inhibitory effect on glycogenolysis. Thus, the aim of the present study was to determine if glucagon has a greater gluconeogenic and a smaller glycogenolytic effect in the presence of both epinephrine and clamped gluconeogenic precursors. Two groups of 18-h fasted conscious dogs were studied. In E, epinephrine was increased, and in G+E+P, glucagon and epinephrine were increased. Gluconeogenic precursors (lactate and alanine) were infused in G+E+P to match the rise that occurred in E. Insulin and glucose levels were also controlled and similar in the two groups. Epinephrine and precursor administration increased glucagon's effect on gluconeogenesis (4.5-fold; P<0.05) and decreased glucagon's effect on glycogenolysis (85%; P=0.08). Thus, in the presence of both hormones, and when the gluconeogenic precursor supply is maintained, gluconeogenic flux is potentiated and glycogenolytic flux is inhibited.
This article has been cited by other articles:
|
|
 |
|
  C. Everett-Grueter, D. S. Edgerton, E. P. Donahue, S. Vaughan, C. A. Chu, D. K. Sindelar, and A. D. Cherrington The effect of an acute elevation of NEFA concentrations on glucagon-stimulated hepatic glucose output Am J Physiol Endocrinol Metab, September 1, 2006; 291(3): E449 - E459. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Jacobson, T. Ansari, J. Potts, and O. P. McGuinness Glucocorticoid-deficient corticotropin-releasing hormone knockout mice maintain glucose requirements but not autonomic responses during repeated hypoglycemia Am J Physiol Endocrinol Metab, July 1, 2006; 291(1): E15 - E22. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Jacobson, T. Ansari, and O. P. McGuinness Counterregulatory deficits occur within 24 h of a single hypoglycemic episode in conscious, unrestrained, chronically cannulated mice Am J Physiol Endocrinol Metab, April 1, 2006; 290(4): E678 - E684. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Guy, D. Sandoval, M. A. Richardson, D. Tate, P. J. Flakoll, and S. N. Davis Differing physiological effects of epinephrine in type 1 diabetes and nondiabetic humans Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E178 - E186. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
